Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Bruni

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Tumori|July 31, 2014
Radiotherapy timing in the treatment of limited-stage small cell lung cancer: the impact of thoracic and brain irradiation on survivalVieri Scotti, Icro Meattini, Ciro Franzese, et al.
Tumori|February 18, 2015
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7th Meeting of AIRO--Young Members Working Group (AIRO Giovani)Pierfrancesco Franco, Berardino De Bari, Patrizia Ciammella, et al.
La Radiologia Medica|December 1, 2021
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative settingGiulio Francolini, Giulia Stocchi, Beatrice Detti, et al.
Cancer|April 6, 2024
Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trialMatthias Guckenberger, Charlotte Billiet, Daniel Schnell, et al.
Cancers|January 21, 2023
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS StudySalvatore Cozzi, Alessio Bruni, Maria Paola Ruggieri, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Alessio Bruni, Vieri Scotti, Maria Alessia Zerella, et al.
British Journal of Cancer|April 28, 2017
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric studyLuca Triggiani, Filippo Alongi, Michela Buglione, et al.
La Radiologia Medica|November 8, 2021
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysisMaurizio Valeriani, Beatrice Detti, Andrei Fodor, et al.
Cancer Treatment and Research Communications|November 3, 2019
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective studySebastiano Buti, Melissa Bersanelli, Alessandro Viansone, et al.
Clinical Lung Cancer|October 24, 2018
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter AnalysisVieri Scotti, Alessio Bruni, Giulio Francolini, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Tumori|July 31, 2014
Radiotherapy timing in the treatment of limited-stage small cell lung cancer: the impact of thoracic and brain irradiation on survivalVieri Scotti, Icro Meattini, Ciro Franzese, et al.
Tumori|February 18, 2015
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7th Meeting of AIRO--Young Members Working Group (AIRO Giovani)Pierfrancesco Franco, Berardino De Bari, Patrizia Ciammella, et al.
La Radiologia Medica|December 1, 2021
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative settingGiulio Francolini, Giulia Stocchi, Beatrice Detti, et al.
Cancer|April 6, 2024
Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trialMatthias Guckenberger, Charlotte Billiet, Daniel Schnell, et al.
Cancers|January 21, 2023
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS StudySalvatore Cozzi, Alessio Bruni, Maria Paola Ruggieri, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Alessio Bruni, Vieri Scotti, Maria Alessia Zerella, et al.
British Journal of Cancer|April 28, 2017
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric studyLuca Triggiani, Filippo Alongi, Michela Buglione, et al.
La Radiologia Medica|November 8, 2021
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysisMaurizio Valeriani, Beatrice Detti, Andrei Fodor, et al.
Cancer Treatment and Research Communications|November 3, 2019
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective studySebastiano Buti, Melissa Bersanelli, Alessandro Viansone, et al.
Clinical Lung Cancer|October 24, 2018
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter AnalysisVieri Scotti, Alessio Bruni, Giulio Francolini, et al.
Pageof 8